Option traders appear to be setting up for a bullish move on Cypress Bioscience, Inc. (CYPB). Traders plowed into 1,305 new call option contracts -- 19.19 times the average volume -- on the stock on Friday. And we know that traders were eager to get into this trade because 100% of the trades came in on the ask price.

Cypress has been in a downtrend since hitting a high around $10.00 in July 2009. The stock closed Friday at $3.39, down 10.79% during the past month.

Continue reading Cypress Bioscience Calls and NetSuite Puts Heating Up

Cypress Bioscience Calls and NetSuite Puts Heating Up originally appeared on BloggingStocks on Fri, 10 Sep 2010 18:30:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Banc of America downgraded shares of Yahoo! (NASDAQ: YHOO) to Neutral from Buy as they believe that even if shareholders accept Microsoft's (NASDAQ: MSFT) offer, the regulatory hurdles are significant.
• Oppenheimer downgraded shares of Goldman Sachs (NYSE: GS) to Perform from Outperform as they believe the current valuation is not sustainable in a year when the company will probably deliver results that will not be substantially better than peers.
• Jefferies lowered its rating on Bankrate (NASDAQ: RATE) to Hold from Buy on valuation, as they believe the run-up in shares reflects expectations for strong Q4 results and guidance.

• SiRF Technology (NASDAQ: SIRF) was downgraded to Hold from Buy at Jefferies, to Market Weight from Overweight at Thomas Weisel and to Perform from Outperform at Oppenheimer.
• Goldman downgraded Posco (NYSE: PKX) to Sell from Neutral.
• Baird downgraded Associated Bancorp (NASDAQ: ASBC) to Neutral from Buy.

Analyst downgrades: YHOO, GS and RATE originally appeared on BloggingStocks on Tue, 05 Feb 2008 10:19:00 EST. Please see our terms for use of feeds.